Reach Medical Opens Ithaca’s First Harm Reduction Medical Practice

The REACH Project (Reach) is opening the first harm reduction medical practice for individuals who use drugs in Ithaca, New York. The practice’s primary focus will be to replace opioid use with Suboxone, a combination of buprenorphine and naloxone that is used to treat opioid addiction disorder.

Additionally, the new practice will also offer primary and acute care and counseling to those battling addiction disorder with other drugs, as well. Suboxone is intended to help block cravings for opioids, reduce the rate of opioid overdose, and prevent addiction, and Reach anticipates that treating people with it will help to . . .